Arcutis Biotherapeutics I... (ARQT)
NASDAQ: ARQT
· Real-Time Price · USD
16.78
0.80 (5.01%)
At close: Aug 15, 2025, 3:05 PM
Arcutis Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 263.46M | 212.82M | 196.54M | 138.71M | 132.06M | 106.39M | 59.61M | 49.04M | 11.66M | 6.47M | 3.69M | 725K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 28.73M | 24.7M | 19.13M | 14.47M | 10.15M | 7.46M | 4.99M | 3.23M | 2.31M | 1.77M | 1.22M | 943K | 866K | 814K | 763K | 718K | 526K | 344K |
Gross Profit | 234.74M | 188.12M | 177.41M | 124.24M | 121.91M | 98.93M | 54.62M | 45.81M | 9.34M | 4.7M | 2.47M | -218K | -866K | -814K | -763K | -718K | -526K | -344K |
Operating Income | -85.84M | -121.3M | -128.4M | -181.93M | -179.77M | -196.46M | -241.1M | -248.36M | -316.2M | -315.26M | -301.63M | -304.49M | -256.82M | -233.07M | -206.53M | -169.31M | -150.53M | -144.08M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -92.33M | -129.12M | -139.39M | -195.19M | -195.39M | -214.05M | -259.09M | -264.85M | -330.82M | -327.23M | -311.46M | -310.76M | -260.04M | -234.64M | -206.36M | -169.08M | -150.3M | -143.71M |
Net Income | -93.27M | -129.72M | -140.04M | -195.53M | -198.76M | -217.42M | -261.78M | -271.11M | -334.05M | -332.05M | -318.33M | -314.04M | -263.31M | -236.33M | -206.36M | -169.08M | -150.3M | -143.71M |
Selling & General & Admin | 249.6M | 238.6M | 229.39M | 220.26M | 209.04M | 196.82M | 184.95M | 173.49M | 161.37M | 143.04M | 122.12M | 103.83M | 84.83M | 68.52M | 60.97M | 48.93M | 38.02M | 32.32M |
Research & Development | 70.98M | 70.82M | 76.42M | 85.72M | 92.45M | 98.37M | 110.58M | 120.68M | 164.17M | 177.16M | 182.44M | 201.12M | 171.99M | 164.55M | 145.56M | 120.37M | 112.51M | 111.76M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 421K | 563K | 523K | 621K | 272K | 173K | 228K | 229K | 372K |
Operating Expenses | 320.57M | 309.42M | 305.81M | 305.98M | 301.49M | 295.19M | 295.52M | 294.17M | 325.54M | 320.19M | 304.56M | 304.94M | 256.82M | 233.07M | 206.53M | 169.31M | 150.53M | 144.08M |
Interest Expense | 18.21M | 22.67M | 27.17M | 29.38M | 30.29M | 30.15M | 29.71M | 28.86M | 26.2M | 20.86M | 15.65M | 8.74M | 3.84M | 1.84M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | -88M | -88M | -88M | -50.87M | 24.52M | 24.52M | 24.52M | -12.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 349.3M | 334.12M | 324.94M | 320.64M | 311.83M | 302.85M | 300.71M | 297.4M | 327.86M | 321.73M | 305.31M | 305.21M | 256.82M | 233.07M | 206.53M | 169.31M | 150.53M | 144.08M |
Income Tax Expense | 944K | 602K | 647K | 349K | 3.37M | 3.37M | 2.69M | 6.25M | 3.23M | 4.81M | 6.87M | 3.14M | 3.06M | 1.41M | -388K | -383K | -307K | -221K |
Shares Outstanding (Basic) | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M | 61.17M | 60.96M | 57.09M | 51.42M | 50.51M | 50.2M | 50.1M | 50M | 47.28M |
Shares Outstanding (Diluted) | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M | 61.17M | 60.96M | 57.09M | 51.42M | 50.51M | 50.2M | 50.1M | 50M | 47.28M |
EPS (Basic) | -0.74 | -1.04 | -1.16 | -1.79 | -2.19 | -2.93 | -3.91 | -4.43 | -5.64 | -5.82 | -5.83 | -6.01 | -5.21 | -4.71 | -4.16 | -3.53 | -3.4 | -3.5 |
EPS (Diluted) | -0.74 | -1.04 | -1.16 | -1.79 | -2.19 | -2.93 | -3.91 | -4.43 | -5.64 | -5.82 | -5.83 | -6.01 | -5.21 | -4.71 | -4.16 | -3.53 | -3.4 | -3.5 |
EBITDA | -68.53M | -101.07M | -109.63M | -163.28M | -163.63M | -182.38M | -227.86M | -234.5M | -303.28M | -305.28M | -294.92M | -301.28M | -255.49M | -232.14M | -205.75M | -168.66M | -150.15M | -143.84M |
EBIT | -74.11M | -106.44M | -112.22M | -165.81M | -165.11M | -183.9M | -229.38M | -235.99M | -304.61M | -306.38M | -295.81M | -301.99M | -256.16M | -232.76M | -206.32M | -169.09M | -150.42M | -144.04M |
Depreciation & Amortization | 5.58M | 5.37M | 2.6M | 2.53M | 1.48M | 1.6M | 1.61M | 1.65M | 1.5M | 1.26M | 1.13M | 910K | 866K | 736K | 605K | 429K | 267K | 193K |